Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J8VU
|
||||
Former ID |
DNC014088
|
||||
Drug Name |
4-(1,2,3-thiadiazol-4-yl)phenyl hexylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529975] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H19N3O2S
|
||||
Canonical SMILES |
CCCCCCNC(=O)OC1=CC=C(C=C1)C2=CSN=N2
|
||||
InChI |
1S/C15H19N3O2S/c1-2-3-4-5-10-16-15(19)20-13-8-6-12(7-9-13)14-11-21-18-17-14/h6-9,11H,2-5,10H2,1H3,(H,16,19)
|
||||
InChIKey |
KWDYSOZHSAWBCY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529975] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.